Russia agrees to produce coronavirus vaccine Sputnik V in India

Moscow, November 27

Russia’s sovereign wealth fund and Indian pharmaceutical company Hetero have agreed to produce over 100 million doses per year in India of the Sputnik V vaccine against COVID-19, according to a statement on the Sputnik V Twitter account on Friday.

Hetero and the Russian Direct Investment Fund (RDIF), which has been backing the vaccine and marketing it globally, plans to start production of Sputnik V in India at the beginning of 2021, the statement said.

Phase II-III trials were ongoing in India, the statement said.

Drugmaker Dr Reddy’s Laboratories Ltd has said it expects late-stage trials to be completed by as early as March 2021. Reuters



Disclaimer: This post has not been edited by our staff and is published from a syndicated feed. The Original Source of this post can be found at Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest

SC stays proceedings before Delhi HC in Amazon Future case

The Supreme Court on Monday stayed the ongoing proceedings before the Delhi High Court in the case related...

Andhra CM releases first tranche of Jagananna Vidya Deevena for 2020-21

Chief Minister Y.S. Jagan Mohan Reddy on Monday released the first instalment of fee reimbursement under Jagananna Vidya Deevena scheme amounting to nearly...

Sensex Drops 883 Points, Nifty Ends Below 14,400 On Rising Covid-19...

<!-- -->Indian equity benchmarks snapped their three-day winning streak and fell sharply on Monday as rising coronavirus infections amid shortage of essential medicines and...

Amitabh Bachchan lauds Irrfan Khan’s son Babil’s Bollywood debut, praises filmmaker’s...

Bollywood superstar Amitabh Bachchan on Monday tweeted out words of praise, support and encouragement for Anvita Dutt Guptan’s upcoming Netflix movie Qala. It stars...

More Articles